Tamara L. Blake

Tamara L. Blake

Auto-generated profile, based on publicly available information

Tamara L. Blake

Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Chest
Verified
Journal Article
Closed access
TBTamara L. Blake
Tamara L. Blake
Anne B. ChangAnne B. Chang
Anne B. Chang
MCMark D. Chatfield
Mark D. Chatfield
HPHelen Petsky
Helen Petsky
LRLeanne T. Rodwell
Leanne T. Rodwell
MMMargaret S. McElrea
Margaret S. McElrea

1 December 2021 in Paediatric Respiratory Reviews
Verified
Journal Article
Closed access
PSPeter D Sly
Peter D Sly
TBTamara Blake
Tamara Blake
MIMohammad Islam
Mohammad Islam


4 July 2016 in Medical Journal of Australia
Verified
Journal Article
Closed access
TBTamara L Blake
Tamara L Blake
Anne B. ChangAnne B. Chang
Anne B. Chang
HPHelen Petsky
Helen Petsky
LRLeanne T Rodwell
Leanne T Rodwell
MBMichael G Brown
Michael G Brown
MMMargaret S McElrea
Margaret S McElrea
Given the importance of spirometry testing on respiratory diagnosis and treatment, there is an urgent need for accurate and validated reference values for Indigenous Australians

7 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ACAndrew James Collaro
Andrew James Collaro
Anne B. ChangAnne B. Chang
Anne B. Chang
Julie M. MarchantJulie M. Marchant
Julie M. Marchant
MCMark D. Chatfield
Mark D. Chatfield
DVDon Vicendese
Don Vicendese
Shyamali DharmageShyamali Dharmage
Shyamali Dharmage
Background: Some but not all previous studies report that pneumonia in children aged less than five years is associated with lower lung function and elevated risk of respiratory disease. To date, none have explored these associations in at-risk populations such as First Nations Australians, whose incidence of early childhood pneumonia is among the highest reported in the world. Methods: This cross-sectional study included 1276 First Nations Australian children/young adults aged 5–25 years recruited from regional/remote Queensland and Northern Territory communities and schools. Associations between pneumonia and both spirometry values and asthma were investigated using linear and logistic regression. Results: Early childhood pneumonia was associated with lower FEV1 and FVC Z-scores, but not FEV1/FVC% Z-scores, when occurring before age three (FEV1 β = −0.42, [95%CI −0.79, −0.04]; FVC β = −0.62, [95%CI −1.14, −0.09]), and between three and five years (β = −0.50, [95%CI −0.88, −0.12]; β = −0.63, [95%CI −1.17, −0.10]), compared to those who never had pneumonia. Similarly, pneumonia occurring when aged before age three years (OR = 3.68, 95%CI 1.96–6.93) and three to five years (OR = 4.81, 95%CI 1.46–15.8) was associated with increased risk of asthma in later childhood. Conclusions: Early childhood pneumonia is associated with lung function deficits and increased asthma risk in later childhood/early adulthood in First Nations Australians. The disproportionate impact of pneumonia on at-risk children must be addressed as a priority.

5 December 2023 in Environmental Research
Verified
Journal Article
Open access
TBThomas Boissière-O'Neill
Thomas Boissière-O'Neill
WLWen R. Lee
Wen R. Lee
TBTamara L. Blake
Tamara L. Blake
PSPeter D Sly
Peter D Sly
DVDwan Vilcins
Dwan Vilcins
Exposure to endocrine-disrupting plasticisers (EDPs), such as phthalates and bisphenols, has been associated with reduced lung function in children and adolescents. However, the existing literature yields conflicting results. This systematic review and meta-analysis aimed to assess the epidemiologic evidence investigating the association between EDP exposure and lung function in children and adolescents. A comprehensive search of five databases identified 25 relevant studies. We employed a random-effects meta-analysis on spirometry measures. The effect size of interest was the change in lung function in standard deviation (SD) units resulting from a two-fold increase in exposure levels. We found that certain phthalates marginally reduced lung function in children. Forced expiratory volume in 1 s (FEV1) was reduced by a two-fold increase in mono-benzyl phthalate (MBzP) (β = -0.025 SD, 95%CI: 0.042, -0.008), mono-ethyl-oxo-hexyl phthalate (MEOHP) (β = -0.035 SD, 95%CI: 0.057, -0.014) and mono-carboxy-nonyl phthalate (MCNP) (β = -0.024 SD, 95%CI: 0.05, -0.003). Forced vital capacity (FVC) was decreased by a two-fold increase in MBzP (β = -0.022 SD, 95%CI: 0.036, -0.008) and MEOHP (β = -0.035 SD, 95%CI: 0.057, -0.014) levels. A two-fold increase in MCNP levels was associated with lower FEV1/FVC (β = -0.023 SD, 95%CI: 0.045, -0.001). Furthermore, a two-fold increase in MEOHP levels reduced forced mid-expiratory flow (FEF25-75) (β = -0.030 SD, 95%CI: 0.055, -0.005) and peak expiratory flow (PEF) (β = -0.056 SD, 95%CI: 0.098, -0.014). Notably, associations were more pronounced in males. Given the potential for reverse causation bias, the association between childhood exposure to EDPs and lung function remains uncertain. Overall, our meta-analysis showed small reductions in lung function with higher phthalate exposure. However, future studies are warranted in younger age groups.